Formulation of Soygurt Mung Bean with Date Juice as Adjuvant Therapy for Diabetes Mellitus
DOI:
https://doi.org/10.11594/nstp.2024.4210Keywords:
Soygurt, mungbean, date juice, chemical analysis, lactic acid bacteria, diabetes mellitusAbstract
One innovative nutritional therapy approach for diabetic mellitus (DM) is modulating the gut microbiota by administering probiotics. Soygurt is a probiotic functional food made from fermenting soy milk with lactic acid bacteria (LAB), which includes bioactive peptides and antioxidants. The use of soybean, mungbean, and date juice as sweeteners is expected to increase the product's physicochemical quality as well as the presence of lactic acid bacteria, maximizing its benefits as a functional meal for DM. This study was an experiment that used a completely randomized design with three treatment formulas comparisons of soybeans and mungbean's (% : %) as follows F1 (25:75), F2 (50:50), and F3 (75:25). Protein content was determined using the biuret method, fat content was identified using the mojonieur method, the reduced sugar content was analyzed using the Nelson Smogyi method, crude fiber content was identified using the gravimetric, and LAB were determined using the Total Plate Count (TPC). The best formula was continued for clinical trials on animals. The result of F3 produced protein of 5.46%, fat of 2.36%, reduced sugar of 4.66%, crude fiber of 3.81%, and a pH of 4.139. The lactic acid bacteria (LAB) count in F1 was 1.9 x 108 CFU/mL. It concluded that soygurt mung bean with date juice can potentially control blood glucose levels due to its high protein and low-fat content.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Miftakhul Jannah, Setyo Sri Rahardjo, Ratih Puspita Febrinasari
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this proceedings agree to the following terms:
Authors retain copyright and grant the Nusantara Science and Technology Proceedings right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this proceeding.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the proceedings published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this proceeding.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See the Effect of Open Access).
